From: Remission of screen-detected metabolic syndrome and its determinants: an observational study
 |  | n (%) | Remission rate (%) | ORa | (95 % C.I.) | P-value |
---|---|---|---|---|---|---|
Baseline determinants | Â | Â | Â | Â | Â | Â |
Age (years) | Â | Â | Â | 0.98 | (0.95 ; 1.01) | 0.27 |
Gender | ♂ | 104 (53.6) | 51.0 | Ref. |  |  |
 | ♀ | 90 (46.4) | 55.6 | 1.20 | (0.68 ; 2.12) | 0.52 |
Ethnicity | Western European | 187 (96.4) | 53.5 | Ref. | Â | Â |
 | Other | 7 (3.6) | 42.9 | 0.65 | (0.14 ; 3.00) | 0.58 |
Higher educated | No | 126 (64.9) | 52.4 | Ref. | Â | Â |
 | Yes | 68 (35.1) | 54.4 | 1.09 | (0.60 ; 1.96) | 0.79 |
Smoking | No | 151 (77.8) | 53.6 | Ref. | Â | Â |
 | Yes | 43 (22.2) | 51.2 | 0.91 | (0.46 ; 1.78) | 0.77 |
Number of metabolic syndrome components | 3 | 149 (76.8) | 59.7 | Ref. | Â | Â |
 | ≥ 4 | 45 (23.2) | 31.1 | 0.30 | (0.15 ; 0.62) | <0.01 |
BMI (kg/m2) | Â | Â | Â | 0.92 | (0.85 ; 1.00) | 0.05 |
HDL cholesterol (mmol/L) | Â | Â | Â | 2.64 | (0.97 ; 7.18) | 0.06 |
Waist circumference (cm) | Â | Â | Â | 0.93 | (0.89 ; 0.97) | <0.001 |
Blood pressure (mmHg) | Systolic | Â | Â | 0.99 | (0.97 ; 1.01) | 0.14 |
 | Diastolic |  |  | 0.96 | (0.93 ; 1.00) | 0.07 |
Triglycerides (mmol/L) | Â | Â | Â | 0.57 | (0.29 ; 1.11) | 0.10 |
Fasting glucose (mmol/L) | Â | Â | Â | 0.55 | (0.36 ; 0.85) | <0.01 |
Follow-up determinants | Â | Â | Â | Â | Â | Â |
≥ 2 consultations with practice nurse | No | 60 (30.9) | 51.7 | Ref. |  |  |
 | Yes | 134 (69.1) | 53.7 | 1.09 | (0.59 ; 2.00) | 0.07 |
Cardiovascular medication, specific for metabolic syndrome component | No | 132 (68.0) | 56.1 | Ref. | Â | Â |
 | Yes | 62 (32.0) | 46.8 | 0.69 | (0.38 ; 1.26) | 0.23 |
Consultation with dietician | No | 133 (68.6) | 55.6 | Ref. | Â | Â |
 | Yes | 61 (31.4) | 47.5 | 0.72 | (0.39 ; 1.33) | 0.30 |
Change in physical activity level (hours/week) | Â | Â | Â | 1.00 | (0.98 ; 1.01) | 0.48 |
Weight loss (kg) | Â | Â | Â | 1.14 | (1.07 ; 1.20) | <0.001 |